Meanwhile, we confirmed that the level of DDX5 enrichment in the IL-1β promoter region of glioma cells was significantly decreased after knockdown of LINC01116, indicating that LINC01116 could recruit DDX5 to the IL-1β promoter region to activate transcription. The gene discussed is IL1B; the disease is central nervous system cancer.